| Serial Number | 98320218 |
| Word Mark | EXO BIOLOGICS |
| Filing Date | Monday, December 18, 2023 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Monday, September 30, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceutical products for the treatment of cancer, lung, eye, skin, gastrointestinal, inflammatory, auto-immune or infectious disorders and diseases; reagents for diagnostic purposes and diagnostic media intended for medical purposes, namely, reagents and media intended for tests, namely, tests based on blood biomarkers for identifying patients affected by diseases or those at risk of developing a disease and for identifying patients responding to specific personalized treatments; biological acidic products and preparations for pharmaceutical purposes, namely, diagnostic preparations for medical use; capsules sold empty for medicines and medical diagnostic reagents tests; chemico-pharmaceutical preparations for the prevention or treatment of cancer, lung, eye, skin, gastrointestinal, inflammatory, auto-immune or infectious disorders and diseases; biopharmaceutical products for the prevention or treatment of cancer, lung, eye, skin, gastrointestinal, inflammatory, auto-immune, or infectious disorders and diseases; chemical preparations for medical, pharmaceutical or veterinary purposes, namely, chemical preparations for diagnosing lung, eye, skin, gastrointestinal, inflammatory, auto-immune, or infectious disorders and diseases, neurodegenerative diseases and cancers; medical diagnostic products and clinical diagnostic products, namely, probes and kits for medical and clinical diagnosis including nucleic acid libraries, nucleic acids on DNA chips; nucleic acid sequences intended for use in chips for medical purposes and medical diagnostic purposes, namely, for decoding genes affected by diseases or revealing the transcriptomic signature of patients affected by diseases; enzymes or enzyme preparations for medical or veterinary purposes, namely, enzyme stabilizers and enzymatic substrates for use as ingredients in medicines for the treatment of diseases; reagents for medical use contained in diagnostic test kits for taking blood samples required for the preservation of the biological material under analysis in order to carry out the test under the appropriate conditions; none of the aforesaid goods being for use in relation to ultrasound-based medical, diagnostic or therapeutic imaging apparatus or devices used for medical, diagnostic or therapeutic imaging and related software |
| Goods and Services | Medical services; veterinary services; medical assistance; hospital services; preparation of prescriptions by pharmacists for geriatric or neurological diagnoses and treatment; health care; telemedicine services; none of the aforesaid services being for use in relation to ultrasound-based medical, diagnostic or therapeutic imaging apparatus or devices used for medical, diagnostic or therapeutic imaging and related software |
| NOT AVAILABLE | BIOLOGICS |
| Goods and Services | Research and development for others of pharmaceutical molecules or biological markers for diagnostic purposes and medicines for treating diseases; chemical analyses; chemical research; chemical analysis services, namely, analysis of RNA genes, tissues and blood samples; scientific research in the nature of biotechnological project studies for identifying people suffering from diseases and to measure the seriousness, prognoses, progression and conversion of the disease and to determine how patients respond to treatments, especially personalized treatments; research and development of new products for others; biological research; biotechnological research; technical research in the field of biotechnology; biotechnological analysis services; laboratory analysis services, namely, quantification of nucleic acid content intended for medical and scientific research; consultancy in the field of biotechnology; DNA and RNA screening for pharmaceutical, veterinary or medical purposes; Consulting services in the field of pharmaceutical research, namely, selection of individuals for clinical trials; none of the aforesaid services being for use in relation to ultrasound-based medical, diagnostic or therapeutic imaging apparatus or devices used for medical, diagnostic or therapeutic imaging and related software |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 30, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 30, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 30, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | EXO Biologics SA |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Liège 4000 BE |
| Event Date | Event Description |
| Saturday, December 23, 2023 | NEW APPLICATION ENTERED |
| Tuesday, January 30, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, July 2, 2024 | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |
| Friday, July 19, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, July 2, 2024 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Wednesday, July 17, 2024 | ASSIGNED TO EXAMINER |
| Friday, July 19, 2024 | NON-FINAL ACTION E-MAILED |
| Friday, July 19, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, September 30, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, September 30, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, September 30, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |